Jennifer Fox
Biochemistry, Genetics and Molecular Biology · University of Michigan
Publications
31
Citations
247
Est. group size
~13
Recurring co-author estimate
Active years
11
Publishing since 2015
Typically publishes in teams of ~10 · 0% small-team papers (≤3 authors) · across 7 venues
- Correction: Hamilton et al. Therapeutics Targeting the Core Apoptotic Machinery. Cancers 2021, 13, 2618
Cancers · 2022
- Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer
Molecular Cancer Therapeutics · 2021
- Therapeutics Targeting the Core Apoptotic Machinery
Cancers · 2021
- Abstract 1342: Development and preclinical evaluation of unique first-in-class small molecule inhibitors of the anti-apoptotic protein FLIP
Cancer Research · 2021
- Abstract LB225: Colon cancer preventive efficacy of licofelone and its analogue LFA-9 in PIRC rat model of FAP
Cancer Research · 2021
- A revised model of TRAIL‐R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosis
EMBO Reports · 2020
- The SCFSkp2 ubiquitin ligase complex modulates TRAIL-R2-induced apoptosis by regulating FLIP(L)
Cell Death and Differentiation · 2020
- DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo models
Journal of Controlled Release · 2020
- Abstract 5220: Development of first-in-class small molecule inhibitors of FLIP which activate caspase-8, the nodal regulator of apoptosis, necroptosis and pyroptosis
Cancer Research · 2020
- Abstract 6364: LFA-9, a dual mPGES-1 and 5-LOX inhibitor, suppresses colon cancer stemness and inflammogen-induced inflammatory response
Cancer Research · 2020
- Abstract 15: Hypertension drug Olmesartan medoxomil promotes colonic tumorigenesis in AOM-induced CRC rat model
Cancer Research · 2020
- Abstract 14: TRAIL inducing small molecule ONC201 prevents intestinal tumors in FAP mouse model
Cancer Research · 2020
- Clinical positioning of the IAP antagonist tolinapant (ASTX660) in colorectal cancer
bioRxiv (Cold Spring Harbor Laboratory) · 2020
- Abstract 382: Development and pre-clinical assessment of a first-in-class small molecule inhibitor of FLIP
Cancer Research · 2019
- Abstract B129: Development and preclinical assessment of a first-in-class small-molecule inhibitor of FLIP
Molecular Cancer Therapeutics · 2018
- Cancer Research×9
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Molecular Cancer Therapeutics×2
- JCI Insight×2
- Cancers×2
- Ahmed S.A. Mady
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Karson J. Kump
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Zaneta Nikolovska‐Coleska
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Patricia Arscott
Biochemistry, Genetics and Molecular Biology · University of Michigan
- Anita C. Bellail
Biochemistry, Genetics and Molecular Biology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile